Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
Clinical trial NCT00925652 · TERMINATED
Trial details
- NCT number
- NCT00925652
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2015-01-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.